Polaryx Therapeutics, Inc.
No trades
−0.17 USD
−30.36 M USD
0.00 USD
About Polaryx Therapeutics, Inc.
Sector
CEO
Alex Yang
Website
Headquarters
Paramus
Founded
2014
Identifiers
3
ISIN US73110F1003
Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. The company was founded by Hahn-Jun Lee on August 22, 2014 and is headquartered in Paramus, NJ.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Polaryx Therapeutics, Inc. stocks are traded under the ticker PLYX.
Yes, you can track Polaryx Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
PLYX net income for the last quarter is −1.43 M USD, while the quarter before that showed −1.01 M USD of net income which accounts for −41.87% change. Track more Polaryx Therapeutics, Inc. financial stats to get the full picture.
No, PLYX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PLYX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Polaryx Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.